About 2 results found for searched term "Cemdisiran" (0.088 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M28435 | Cemdisiran, terminal sugar modification- | Complement System |
| Cemdisiran, terminal sugar modification- is an investigational N-acetylgalactosamine-conjugated RNAi agent. Cemdisiran, a siRNA-targeting C5 mRNA, suppresses liver production of complement component C5. | ||
| M59342 | Cemdisiran | Others |
| Cemdisiran can be used for the research of paroxysmal nocturnal hemoglobinuria(PNH), atypical hemolytic uremic syndrome (a HUS) IgA Nephropathy (IgAN), and myasthenia gravis (MG). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
